This is a single center, randomized, single-blind, placebo-controlled study to evaluate the safety and biochemical effects of niacinamide on metabolic parameters of the kidney in patients undergoing cardiac surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Enrollment
55
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Changes from baseline in serum metabolite profile of niacinamide
Time frame: Baseline and days 1 through 4
Changes from baseline in urine metabolite profile of niacinamide
Time frame: Baseline and days 1 through 4
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.